글로벌 옴스크 출혈열(OHF) 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 옴스크 출혈열(OHF) 치료 시장

옴스크 출혈열(OHF) 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 상기 연구 예측 기간 동안 6.80%의 CAGR로 성장하고 있다고 분석합니다. 신흥국에서 OHF 발병률이 빠르게 증가하고 뇌염 발병 가능성이 증가함에 따라 시장 성장이 촉진될 가능성이 높습니다.

게다가 연구 활동이 증가하고 환자가 지지 치료와 항바이러스 요법에 크게 의존하는 것도 시장 성장을 촉진합니다. 게다가 연구 개발이 증가하고 의료비가 증가하는 것은 시장 성장의 기회로 작용합니다. 하지만 때로는 항바이러스 약물, 약물 리콜, 엄격한 규제 프레임워크 등과 관련된 부작용이 글로벌 옴스크 출혈열(OHF) 치료 시장을 방해할 수 있습니다.

Omsk hemmorhagic fever (OHF) is caused due to infection caused by the Omsk hemmorhagic fever virus (OHFV). This virus belongs to the virus family Flaviviridae. The primary carrier of OHFV are infected ticks which transmits this disease to rodents most commonly to the Dermacenor reticulatus, Ixodes persulcatus among others. Human are also prone to OHFV infection through tick bites or through the contact with blood, urine and faeces of an infected, dead or sick animal. Recreation activities enhance the chances of OHFV infections. The most common symptoms reported after 3-8 days of infection includes fever, chills, headache and severe muscle pain with vomiting, bleeding problems and gastrointestinal symptoms. Infected person also experiences low platelet counts, abnormal blood flow, low RBCs and WBCs count. The severe symptoms reported after the infections are encephalitis (inflammation of brain) and fever. People living in Siberia who trap muskrats are highly prone to OHFV infection. Till now no such specific treatment is available for OHFV but, it can be manifested up to an extent by the application of supportive care and antiviral therapy. Realdiron and ribavirin have been shown effective up an extent to treat OHFV related symptoms.

As per the studies conducted, this has been reported that it is one of the less reported viruses and are usually confined to endemic regions specifically Siberian region among others. Moreover, people in the range of age 40-50 years have more chance of getting infection. As the geriatric population is increasing worldwide the chances of infection also enhances and hence expected to provide market with the lucrative growth. It is also estimated that Omsk hemorrhagic fever (OHF) treatment market is growing with the CAGR of 5.80% in 2020.

This Omsk hemorrhagic fever (OHF) treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Omsk Hemorrhagic Fever (OHF) Treatment Market Scope and Market Size

Omsk hemorrhagic fever (OHF) treatment market is segmented on the basis of treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the Omsk hemorrhagic fever (OHF) treatment market is segmented into supportive therapy and antiviral therapy. Antiviral therapy is further sub-segmented into realdiron and ribavirin.
• On the basis of route of administration, the Omsk hemorrhagic fever (OHF) treatment market is segmented into oral, parenteral and others.
• On the basis of end-users, the Omsk hemorrhagic fever (OHF) treatment market is segmented into clinics, hospitals and others.
• On the basis of distribution channel, the Omsk hemorrhagic fever (OHF) treatment market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. 

Omsk Hemorrhagic Fever (OHF) Treatment Market Country Level Analysis

Omsk hemorrhagic fever (OHF) treatment market is analysed and market size information is provided by country, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Omsk hemorrhagic fever (OHF) treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the rising number of Ixodes cookie in the Midwest and Canada and increasing research and development activities is also boosting the growth of market.  Europe is also expected to grow exponentially due to increasing trapping of muskrats. Asia-Pacific is expected to account for the largest market share owing to increasing rodent species and increasing number of travellers is an another factor boosting the Asia Pacific market.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

옴스크 출혈열(OHF) 치료 시장은 또한 환자 분석, 예후 및 치료법에 대한 자세한 시장 분석을 제공합니다. 유병률, 발생률, 사망률, 준수율은 보고서에서 사용할 수 있는 일부 데이터 변수입니다. 시장 성장에 대한 역학의 직접 또는 간접 영향 분석을 분석하여 성장 기간 동안 시장을 예측하기 위한 보다 견고하고 코호트 다변량 통계 모델을 만듭니다.

경쟁 환경 및 옴스크 출혈열(OHF) 치료 시장 점유율 분석

옴스크 출혈열(OHF) 치료 시장 경쟁 구도는 경쟁사별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 옴스크 출혈열(OHF) 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

옴스크 출혈열(OHF) 치료 시장에서 다루는 주요 업체는 Nortec Quimica, Bausch Health Companies Inc., Zydus Cadila, Hetero Healthcare Limited, AdvaCare Pharma, Aurobindo Pharma, Wellona Pharma, LUPIN, Merck Sharp & Dohme Corp.(Merck & Co., Inc.의 자회사), Baxter 등 국내 및 글로벌 업체입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60897